REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

New COVID-19 Antigen Test Developed at Sheba Medical Center Could Allow a Return to Normalcy at Airports

COVID-19 Antigen
With a wait time of only 15 minutes, widespread use of the new COVID-19 antigen tests is expected to reduce social distancing that limits turnover at airports and allow ‘business as usual’ for duty-free shops and restaurants.

Sheba Medical Center has partnered with El-Al Airlines to offer free COVID-19 antigen tests for the purpose of ensuring the safety of every passenger and crew member departing from Ben-Gurion Airport. By testing every passenger and crew member with no proof of immunization before a flight, a higher level of safety can be achieved. In turn, this can facilitate reduced social distancing, which limits turnover at airports, and allow a return to ‘business as usual’ for terminal duty-free shops and restaurants.

Israeli El-Al Airlines began evaluating the new COVID-19 antigen testing system last week for passengers of its flight to JFK Airport in New York. If successful, the new protocol could become a new global standard for travel in the coronavirus era.

“This is the first time in the world you will know that you have verified that everyone onboard is clean and non-contagious for coronavirus,” said Leehu Hacohen, El-Al’s Vice President of Operations, who added: “We can then open up all of these shops and go back to the familiar experience of flight and terminal commerce.”

Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More